Clinical trial
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
NCT01246232 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
- Lead sponsor
- Imperial College London
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- March 31, 2015
- Enrollment
- 69 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.